IL1B and diabetes mellitus: The keywords used for PubMed were ‘(diabetes OR hyperglycemia OR prediabetes OR insulin resistance OR glucose intolerance) AND (canakinumab OR interleukin-1 beta antagonist)’ in combination with Medical Subject Headings (MeSH) terms.